Classical Hodgkin lymphoma (CHL) is a type of blood cancer that starts in the lymphatic system, which is part of the body’s immune system. It develops when abnormal white blood cells called Reed–Sternberg cells grow uncontrollably and crowd out healthy cells.
CHL most often affects lymph nodes in the neck, chest, or underarms, but it can spread to other areas of the body. It is considered one of the most treatable forms of cancer, especially when detected early.
Common symptoms are painless swelling of lymph nodes, fever and night sweats, unexplained weight loss, persistent fatigue and itchy skin.
A common misconception is that Hodgkin lymphoma is always fatal. In reality, with timely diagnosis and advanced treatments, most patients achieve long-term remission and many are cured.
Modern treatment options include:
With these therapies, survival rates for classical Hodgkin lymphoma are very high, and most patients can return to a normal quality of life.
People need classical Hodgkin lymphoma treatment to stop the spread of cancer, restore normal immune function, and prevent life-threatening complications. Without treatment, the abnormal Reed–Sternberg cells can grow uncontrollably, weaken the immune system, and spread to other organs. While the disease is highly treatable, timely care is essential. Modern therapies give patients an excellent chance of remission and a good quality of life.
The exact causes of classical Hodgkin lymphoma are not fully understood, but some factors may increase the risk:
Symptoms depend on how far the disease has progressed and which lymph nodes or organs are affected. Early signs can be mild, while advanced stages may cause more noticeable problems. Common symptoms include:
These symptoms lead to treatment when tests confirm the presence of classical Hodgkin lymphoma. Because the disease can spread through the lymphatic system and weaken immunity, early diagnosis is important. Starting treatment promptly helps control the cancer, relieve symptoms, and improve long-term survival.
How to Detect Classical Hodgkin Lymphoma?
Early detection of classical Hodgkin lymphoma allows doctors to begin treatment at the right time and improve outcomes. If this condition is suspected, doctors may recommend the following tests:
Finding classical Hodgkin lymphoma early and beginning the right treatment can help stop the cancer from spreading, relieve symptoms, and improve survival outcomes. If you or a loved one experiences these signs, myheco can connect you with leading haematology and oncology specialists at trusted hospitals.
Some of the world’s most advanced cancer hospitals offer specialised care for patients with Classical Hodgkin Lymphoma (CHL) and other blood cancers. These centres provide comprehensive haematology and oncology services, including chemotherapy, immunotherapy, targeted therapy, and stem cell transplantation, supported by experienced haematologists and multidisciplinary teams. They also offer international patient services and structured follow-up care to ensure continuity of treatment.
Leading hospitals for Classical Hodgkin Lymphoma treatment include:
.jpg)
.png)
.png)
%20%E2%80%93%20Banjara%20Hills%2C%20Hyderabad.png)
.png)
.png)
.png)
These hospitals follow evidence-based treatment protocols, offer access to advanced technologies, and provide coordinated care for international patients seeking treatment for Classical Hodgkin Lymphoma.
The average cost of classical Hodgkin lymphoma (CHL) treatment ranges from $3,500 to $9,000 in India and from $11,000 to $14,000 in Thailand. The final expense may vary depending on factors such as the stage of the disease, choice of hospital, duration of therapy, and whether advanced options like stem cell transplantation are required. Before checking the detailed table of treatment-wise costs, it is important to understand the factors that influence these costs the most, including diagnostics, hospital stay, medications, and supportive care.
Several elements can impact the overall cost of treatment:
Note: India has become a preferred destination for advanced cancer treatment, offering world-class care at a fraction of the international cost. Patients benefit from expert oncologists, modern medical technology, and affordable access to high-quality generic medicines, making treatment both effective and economical.
Note: Thailand has established itself as a premium destination for cancer treatment, offering world-class hospitals, advanced technology, and internationally trained oncologists. Patients choose Thailand not only for its high-quality medical care but also for its holistic approach, combining clinical excellence with exceptional comfort and service standards.
The above figures are approximate and can vary based on the hospital, location, and individual patient requirements. Always consult the healthcare provider for the most accurate and up-to-date pricing.
The currency conversion rates in the table above are based on data from April 2026.
For a detailed cost estimate and guidance on treatment options, patients can contact myheco to connect with leading hospitals.
In a study for Classical Hodgkin Lymphoma (cHL), it was revealed that cHL treatment has improved, leading to high 5-year survival rates. However, survival outcomes vary with age.
Leading hospitals provide patient-centred care with accurate diagnosis, personalised treatment plans, and ongoing support. Their approach includes:
This integrated approach helps achieve remission, lowers the chance of recurrence, and improves long-term survival and quality of life for patients with classical Hodgkin lymphoma.
Dr Mallikarjun Kalashetty, Manipal Hospital, Old Airport Road, shares his expert insights on Hodgkin’s lymphoma, a type of blood cancer that accounts for around 10-15% of all lymphomas. He highlights that it often presents as neck swellings, accompanied by symptoms such as fever, night sweats, and weight loss.
He explains that diagnosis is confirmed through lymph node biopsy and immunohistochemistry, which helps in accurately subclassifying the disease. Traditionally managed with systemic chemotherapy, Hodgkin’s lymphoma treatment has significantly advanced in recent years.
At Manipal Hospital, Old Airport Road, these therapies are integrated into care, offering highly effective outcomes with minimal side effects.
Myheco offers dedicated guidance and end-to-end assistance for international patients seeking advanced treatment worldwide. From connecting you with leading specialists to arranging online consultations, myheco ensures a smooth and informed treatment journey.
Choosing myheco means expert care, faster access, and comprehensive support throughout your treatment journey.
Note: Myheco does not provide medical advice.
Mrs Matlubakhon Sotvoldieva, a 33-year-old nurse from Uzbekistan, was diagnosed with classical Hodgkin’s lymphoma. She initially received ABVD chemotherapy in Uzbekistan, but the disease returned after a few years. Following salvage chemotherapy, she travelled to Max Super Speciality Hospital, Shalimar Bagh, India, for advanced care.
Under the guidance of Dr Amrita Ramaswami, she underwent an autologous stem cell (bone marrow) transplant with BEAM conditioning. Though she faced serious complications such as septic shock and periengraftment syndrome, strong ICU support ensured her safe recovery.
Her post-transplant PET CT scans have shown encouraging results, and she continues regular follow-up at Max Hospital. Today, Mrs Sotvoldieva’s story reflects the hope and success of advanced treatment for relapsed Hodgkin’s lymphoma.
✅ Share your medical reports
✅ Receive personalised treatment plans from leading hospitals
✅ Choose the option that suits you best
✅ Let us handle the arrangements
Yes, classical Hodgkin lymphoma is one of the most treatable forms of cancer. Most patients achieve long-term remission or cure when diagnosed early. Modern therapies contribute to excellent outcomes.
Treatment depends on the stage of the disease, the patient’s age, and overall health. Options include chemotherapy, radiation therapy, targeted drugs, immunotherapy (monoclonal antibodies), or stem cell transplantation in selected cases.
Recovery varies depending on the therapy used. Chemotherapy and radiation are typically given in cycles over several months, while targeted therapy and immunotherapy may continue longer but often with manageable side effects. Follow-up care is essential to monitor response and prevent recurrence.
There is no proven way to prevent classical Hodgkin lymphoma, as the exact cause is unknown. Maintaining overall health, avoiding exposure to harmful chemicals, and seeking prompt medical attention for early symptoms can support early detection.
Myheco supports patients by offering online consultations, arranging second opinions, connecting with leading haematologists and oncologists, providing cost estimates, issuing medical visa invitation letters, arranging travel and hospital transfers, and offering multilingual assistance throughout the treatment journey.
India’s leading hospitals for Classical Hodgkin Lymphoma treatment include Apollo Proton Cancer Centre, Apollo Cancer Institute, SIMS Hospital, MGM Healthcare, Rela Hospital, and Asian Institute of Nephrology & Urology (AINU) in Chennai; Manipal Hospital, Apollo Hospital, and Fortis Hospital in Bangalore; Max Hospital, BLK-Max Super Speciality Hospital, Manipal Hospital Dwarka, Medanta – The Medicity, Indraprastha Apollo Hospital, Apollo Athena Women’s Cancer Hospital, and Fortis Hospital in Delhi; Nanavati Max Super Speciality Hospital, Apollo Hospital, and Fortis Hospital in Mumbai; and Apollo Hospital and Asian Institute of Nephrology & Urology (AINU) in Hyderabad. These centres provide multidisciplinary oncology care, advanced diagnostics, chemotherapy, immunotherapy, targeted therapy, and stem cell transplantation for comprehensive lymphoma management.
In Thailand, Samitivej Sukhumvit Hospital in Bangkok is internationally recognised for advanced haematology services, chemotherapy, targeted therapy, immunotherapy, and integrated cancer care. The hospital also provides structured international patient services, supporting patients travelling from overseas for specialised treatment.
DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE
The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material or content on this site is intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website - www.myheco.com
.png)